Biotechnology · Healthcare
Chief Accounting Officer
2026-03-13–present
Chief Accounting Officer
MiNK Therapeutics, Inc. (INKT)Equibles does not estimate personal net worth.
Get an email with a short summary when MiNK Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INKT alertsAustin Charette is recorded as Chief Accounting Officer at MiNK Therapeutics, Inc. (INKT) since March 13, 2026. MiNK Therapeutics, Inc. reported in an 8-K filed March 19, 2026 that Austin Charette was appointed Principal Accounting Officer, effective March 13, 2026. MiNK Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MiNK Therapeutics, Inc. includes Melissa Orilall (CFO), Dr. John Holcomb (Board Member), Jennifer Buell (Board Member) and 4 others.
“Also effective March 13, 2026, the Company's Board of Directors appointed Austin Charette, Agenus' current Senior Director, Financial Reporting and Compliance, to serve as the Company's Principal Accounting Officer.”
2026-03-13–present
Biotechnology · Healthcare
Chief Accounting Officer
2026-03-13–present